Knobbe Martens
Kurt Jacobs is currently a Summer Associate at Knobbe Martens since May 2023 and is pursuing a Juris Doctorate at The Ohio State University Moritz College of Law, expected to graduate in May 2024. Prior experience includes serving as a Patent Agent at Global Graphene Group from June 2017 to July 2021, where responsibilities involved patent-related tasks, and as a Research Assistant at Ohio State University from July 2015 to January 2017, focusing on editing technical papers and compiling research in nano engineering. Earlier roles include managing programming and technology initiatives for children at Funutation Tekademy LLC in the summer of 2014 and working in batching at Rose Packing Company in 2011. Academic credentials include a Bachelor’s degree from The Ohio State University, earned between 2012 and 2017, and a high school diploma from Barrington High School obtained in 2012.
This person is not in any teams
This person is not in any offices
Knobbe Martens
2 followers
Our firm boasts IP law’s largest and most experienced biotechnology group, with more than 60 attorneys and scientists representing clients in all stages of their business and technology development. Our clients are innovators in a variety of disciplines including PCR, molecular tools and probes, immunology (antibodies and other binding proteins), cell varieties and uses (including stem cells) and biological polymers, to name but a few. Our expertise across the entire biotech landscape gives us great insight into specific technologies, systems and markets. More importantly, our holistic understanding of the interrelated technologies and systems typically involved in a single invention allows us to provide coordinated guidance and counsel from inception though introduction. Working in collaboration with more than 300 IP firms worldwide, we effect patent, trademark, copyright, and other filings, and direct oppositions, cancellations, and litigation matters in over 120 countries. We have considerable experience in negotiating and drafting traditional licensing agreements as well as agreements for strategic alliances, partnerships and joint ventures. We also maintain a talented litigation department adept in all aspects of biotechnology IP law, including the Biosimilars legislation. Our extensive Hatch-Waxman litigation experience combined with our understanding of the biotechnology industry uniquely positions Knobbe Martens to help clients develop and implement litigation strategies designed to maximize their place in the Biosimilars market place. In addition, we have considerable experience litigating before the U.S. Court of Appeals for the Federal Circuit and the International Trade Commission. Our attorneys have experience in all areas of Biotechnology, including: Aesthetic & Cosmetic Biotechnology Antibodies & Immunology Biofuels Biological Manufacturing Of Chemicals Biologics Diagnostic Tools Genomics Industrial Enzymes Peptides Personalized Medicine Research Tools & Reagents Stem Cells & Regenerative Medicine Synthetic Biology & Nanotechnology Therapeutics Tissue Engineering Transgenic Animals Vaccines